S. aureus colonisation can complicate management of atopic dermatitis. The two pillars of treatment are a correct cleansing routine, and careful selection of antimicrobial/anti-inflammatory therapy guided by antibiotic stewardship
Atopic dermatitis and Staphylococcus aureus secondary skin infections
Printable Q&A for Offline SubmissionQuiz-summary
0 of 15 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Information
You have already completed the module before. Hence you can not start it again.
Module is loading…
You have to finish following quiz, to start this quiz:
Results
Results
Time has elapsed
Categories
- Not categorized 0%
-
Thank you, we will review your submission and notify you of your results via email.
If not received within 5 hours due to spam, don’t worry, it will show in your profile.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Answered
- Review
- Question 1 of 15
1. Question
Question 1. A characteristic feature of patients with AD, compared to healthy individuals, is the abundant presence of:
- Question 2 of 15
2. Question
Question 2. S. aureus can be isolated from what percentage of AD skin lesions?
- Question 3 of 15
3. Question
Question 3. Patients with AD are strongly predisposed to the development of secondary staphylococcal infections due to:
- Question 4 of 15
4. Question
Question 4. The number of S. aureus organisms in AD patients is 100-fold higher than in healthy individuals:
- Question 5 of 15
5. Question
Question 5. Which statement is false? Skin colonisation by S. aureus in those with AD:
- Question 6 of 15
6. Question
Question 6. The S. aureus strains isolated from the skin of patients with AD release which toxins?
- Question 7 of 15
7. Question
Question 7. What percentage of S. aureus strains is estimated to produce superantigens?
- Question 8 of 15
8. Question
Question 8. SSAgs:
- Question 9 of 15
9. Question
Question 9. S. aureus colonises up to 60% of AD patients:
- Question 10 of 15
10. Question
Question 10. Colonisation by S. aureus in patients with AD may increase:
- Question 11 of 15
11. Question
Question 11. What percentage of S. aureus strains colonising the skin in patients with AD are estimated to be MRSA strains?
- Question 12 of 15
12. Question
Question 12. The mainstay of anti-inflammatory therapy in the management of chronic AD is:
- Question 13 of 15
13. Question
Question 13. Which statement is false?
- Question 14 of 15
14. Question
Question 14. Which statement is true?
- Question 15 of 15
15. Question
Question 15. Which of the listed antibiotics are recommended as first-line therapy for infected AD?
Do you like this? Share with a colleague
